PSD-95

Product Number 104904

The Simoa® PSD-95 Advantage PLUS Assay measures postsynaptic density protein 95 (PSD-95), a key synaptic protein that provides critical insights into synaptic integrity. PSD-95 is an essential component of synaptic signaling complexes, playing a pivotal role in synaptic plasticity and cognitive function. Research has linked increased PSD-95 levels in cerebrospinal fluid (CSF) with neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). As an emerging biomarker for synaptic degeneration, PSD-95 may also correlate with cognitive decline, offering valuable data for understanding disease progression and developing targeted treatments.

With subpicogram sensitivity, full automation on the HD-X, and lot-matched kits, the Simoa® PSD-95 Advantage PLUS Assay provides reliable quantification of PSD-95 with a streamlined workflow, scalability, and consistency for research projects of all sizes.

Certificates of Analysis

Applications and Intended Use

Simoa® PSD-95 Advantage PLUS is a digital immunoassay for the quantitative determination of PSD concentrations in human CSF, serum and EDTA plasma samples.

Assay Specifications

  • Compatible instruments: HD-X
  • Analytical Lower Limit of Quantification (LLOQ): 0.823 pg/mL
  • Lower Limit of Detection (LOD): 0.173 pg/mL
  • Dynamic range: 0-4800 pg/mL

(For detailed specifications, please refer to the PSD-95 Advantage PLUS datasheet)

Kit Contents

The assay kit includes all necessary reagents and controls to perform 96 tests.

Related Products

Simoa® Assays for Neurology Biomarkers

All Simoa® Assays

HD-X™ Automated Immunoassay Analyzer